The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Maria Gomez

Maria Gomez


Maria Gomez

Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways.


  • Nicholas S Kirkby
  • Melissa V Chan
  • Anne K Zaiss
  • Eliana Garcia Vaz
  • Jing Jiao
  • Lisa Berglund
  • Elena F Verdu
  • Blerina Ahmetaj-Shala
  • John L Wallace
  • Harvey R Herschman
  • Maria Gomez
  • Jane A Mitchell

Summary, in English

Cyclooxygenase-2 (COX-2) is an inducible enzyme that drives inflammation and is the therapeutic target for widely used nonsteroidal antiinflammatory drugs (NSAIDs). However, COX-2 is also constitutively expressed, in the absence of overt inflammation, with a specific tissue distribution that includes the kidney, gastrointestinal tract, brain, and thymus. Constitutive COX-2 expression is therapeutically important because NSAIDs cause cardiovascular and renal side effects in otherwise healthy individuals. These side effects are now of major concern globally. However, the pathways driving constitutive COX-2 expression remain poorly understood. Here we show that in the kidney and other sites, constitutive COX-2 expression is a sterile response, independent of commensal microorganisms and not associated with activity of the inflammatory transcription factor NF-κB. Instead, COX-2 expression in the kidney but not other regions colocalized with nuclear factor of activated T cells (NFAT) transcription factor activity and was sensitive to inhibition of calcineurin-dependent NFAT activation. However, calcineurin/NFAT regulation did not contribute to constitutive expression elsewhere or to inflammatory COX-2 induction at any site. These data address the mechanisms driving constitutive COX-2 and suggest that by targeting transcription it may be possible to develop antiinflammatory therapies that spare the constitutive expression necessary for normal homeostatic functions, including those important to the cardiovascular-renal system.


  • Diabetic Complications
  • Cardiovascular Research - Immunity and Atherosclerosis
  • Vascular Physiology
  • EXODIAB: Excellence of Diabetes Research in Sweden

Publishing year







Proceedings of the National Academy of Sciences





Document type

Journal article


National Acad Sciences


  • Cardiac and Cardiovascular Systems



Research group

  • Diabetic Complications
  • Cardiovascular Research - Immunity and Atherosclerosis
  • Vascular Physiology


  • ISSN: 1091-6490